| Year |
Citation |
Score |
| 2019 |
Holmstrom SR, Wijayatunge R, McCrum K, Mgbemena VE, Ross TS. Functional Interaction of BRCA1 and CREBBP in Murine Hematopoiesis. Iscience. 19: 809-820. PMID 31499338 DOI: 10.1016/J.Isci.2019.08.031 |
0.432 |
|
| 2018 |
Wijayatunge R, Holmstrom SR, Foley SB, Mgbemena VE, Bhargava V, Perez GL, McCrum K, Ross TS. Deficiency of the Endocytic Protein Leads to Decreased expression, Low Phosphocholine, and Kypholordosis. Molecular and Cellular Biology. PMID 30224518 DOI: 10.1128/Mcb.00385-18 |
0.493 |
|
| 2017 |
Mgbemena VE, Signer RA, Wijayatunge R, Laxson T, Morrison SJ, Ross TS. Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function. Cell Reports. 18: 947-960. PMID 28122244 DOI: 10.1016/J.Celrep.2016.12.075 |
0.38 |
|
| 2015 |
Tang H, Sebti S, Titone R, Zhou Y, Isidoro C, Ross TS, Hibshoosh H, Xiao G, Packer M, Xie Y, Levine B. Decreased BECN1 mRNA Expression in Human Breast Cancer is Associated with Estrogen Receptor-Negative Subtypes and Poor Prognosis. Ebiomedicine. 2: 255-263. PMID 25825707 DOI: 10.1016/J.Ebiom.2015.01.008 |
0.318 |
|
| 2014 |
Ross TS, Mgbemena VE. Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia. Molecular & Cellular Oncology. 1: e963450. PMID 27308345 DOI: 10.4161/23723548.2014.963450 |
0.411 |
|
| 2014 |
Messa M, Fernández-Busnadiego R, Sun EW, Chen H, Czapla H, Wrasman K, Wu Y, Ko G, Ross T, Wendland B, De Camilli P. Epsin deficiency impairs endocytosis by stalling the actin-dependent invagination of endocytic clathrin-coated pits. Elife. 3: e03311. PMID 25122462 DOI: 10.7554/Elife.03311 |
0.323 |
|
| 2014 |
Philips ST, Hildenbrand ZL, Oravecz-Wilson KI, Foley SB, Mgbemena VE, Ross TS. Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells. Oncogene. 33: 5379-90. PMID 24240679 DOI: 10.1038/Onc.2013.484 |
0.781 |
|
| 2013 |
Soyombo AA, Wu Y, Kolski L, Rios JJ, Rakheja D, Chen A, Kehler J, Hampel H, Coughran A, Ross TS. Analysis of induced pluripotent stem cells from a BRCA1 mutant family. Stem Cell Reports. 1: 336-49. PMID 24319668 DOI: 10.1016/J.Stemcr.2013.08.004 |
0.382 |
|
| 2013 |
Foley SB, Hildenbrand ZL, Soyombo AA, Magee JA, Wu Y, Oravecz-Wilson KI, Ross TS. Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. Cell Reports. 5: 51-60. PMID 24095735 DOI: 10.1016/J.Celrep.2013.08.037 |
0.36 |
|
| 2013 |
Ames HM, Wang AA, Coughran A, Evaul K, Huang S, Graves CW, Soyombo AA, Ross TS. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases. Molecular and Cellular Biology. 33: 3580-93. PMID 23836884 DOI: 10.1128/Mcb.00473-13 |
0.772 |
|
| 2011 |
Ames HM, Bichakjian CK, Liu GY, Oravecz-Wilson KI, Fullen DR, Verhaegen ME, Johnson TM, Dlugosz AA, Ross TS. Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit. The Journal of Investigative Dermatology. 131: 2113-20. PMID 21697888 DOI: 10.1038/Jid.2011.171 |
0.743 |
|
| 2009 |
Oravecz-Wilson KI, Philips ST, Yilmaz OH, Ames HM, Li L, Crawford BD, Gauvin AM, Lucas PC, Sitwala K, Downing JR, Morrison SJ, Ross TS. Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell. 16: 137-48. PMID 19647224 DOI: 10.1016/J.Ccr.2009.06.007 |
0.754 |
|
| 2008 |
Jain RN, Al-Menhali AA, Keeley TM, Ren J, El-Zaatari M, Chen X, Merchant JL, Ross TS, Chew CS, Samuelson LC. Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice. The Journal of Clinical Investigation. 118: 2459-70. PMID 18535670 DOI: 10.1172/Jci33569 |
0.348 |
|
| 2008 |
Graves CW, Philips ST, Bradley SV, Oravecz-Wilson KI, Li L, Gauvin A, Ross TS. Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues. Cancer Research. 68: 1064-73. PMID 18281481 DOI: 10.1158/0008-5472.Can-07-5892 |
0.746 |
|
| 2007 |
Bradley SV, Smith MR, Hyun TS, Lucas PC, Li L, Antonuk D, Joshi I, Jin F, Ross TS. Aberrant Huntingtin interacting protein 1 in lymphoid malignancies. Cancer Research. 67: 8923-31. PMID 17875735 DOI: 10.1158/0008-5472.Can-07-2153 |
0.797 |
|
| 2007 |
Bradley SV, Hyun TS, Oravecz-Wilson KI, Li L, Waldorff EI, Ermilov AN, Goldstein SA, Zhang CX, Drubin DG, Varela K, Parlow A, Dlugosz AA, Ross TS. Degenerative phenotypes caused by the combined deficiency of murine HIP1 and HIP1r are rescued by human HIP1. Human Molecular Genetics. 16: 1279-92. PMID 17452370 DOI: 10.1093/Hmg/Ddm076 |
0.807 |
|
| 2007 |
Bradley SV, Holland EC, Liu GY, Thomas D, Hyun TS, Ross TS. Huntingtin interacting protein 1 is a novel brain tumor marker that associates with epidermal growth factor receptor. Cancer Research. 67: 3609-15. PMID 17440072 DOI: 10.1158/0008-5472.Can-06-4803 |
0.786 |
|
| 2006 |
Smith MR, Joshi I, Jin F, Bradley SV, Ross TS. Role of Huntingtin Interacting Protein HIP-1 in Non-Hodgkin’s Lymphoma. Blood. 108: 2384-2384. DOI: 10.1182/blood.v108.11.2384.2384 |
0.718 |
|
| 2005 |
Mills IG, Gaughan L, Robson C, Ross T, McCracken S, Kelly J, Neal DE. Huntingtin interacting protein 1 modulates the transcriptional activity of nuclear hormone receptors Journal of Cell Biology. 170: 191-200. PMID 16027218 DOI: 10.1083/Jcb.200503106 |
0.438 |
|
| 2005 |
Bradley SV, Oravecz-Wilson KI, Bougeard G, Mizukami I, Li L, Munaco AJ, Sreekumar A, Corradetti MN, Chinnaiyan AM, Sanda MG, Ross TS. Serum antibodies to huntingtin interacting protein-1: a new blood test for prostate cancer. Cancer Research. 65: 4126-33. PMID 15899803 DOI: 10.1158/0008-5472.Can-04-4658 |
0.711 |
|
| 2004 |
Hyun TS, Li L, Oravecz-Wilson KI, Bradley SV, Provot MM, Munaco AJ, Mizukami IF, Sun H, Ross TS. Hip1-related mutant mice grow and develop normally but have accelerated spinal abnormalities and dwarfism in the absence of HIP1. Molecular and Cellular Biology. 24: 4329-40. PMID 15121852 DOI: 10.1128/Mcb.24.10.4329-4340.2004 |
0.79 |
|
| 2004 |
Hyun TS, Ross TS. HIP1: trafficking roles and regulation of tumorigenesis. Trends in Molecular Medicine. 10: 194-9. PMID 15059611 DOI: 10.1016/J.Molmed.2004.02.003 |
0.784 |
|
| 2004 |
Oravecz-Wilson KI, Kiel MJ, Li L, Rao DS, Saint-Dic D, Kumar PD, Provot MM, Hankenson KD, Reddy VN, Lieberman AP, Morrison SJ, Ross TS. Huntingtin Interacting Protein 1 mutations lead to abnormal hematopoiesis, spinal defects and cataracts. Human Molecular Genetics. 13: 851-67. PMID 14998932 DOI: 10.1093/Hmg/Ddh102 |
0.495 |
|
| 2004 |
Hyun TS, Rao DS, Saint-Dic D, Michael LE, Kumar PD, Bradley SV, Mizukami IF, Oravecz-Wilson KI, Ross TS. HIP1 and HIP1r stabilize receptor tyrosine kinases and bind 3-phosphoinositides via epsin N-terminal homology domains. The Journal of Biological Chemistry. 279: 14294-306. PMID 14732715 DOI: 10.1074/Jbc.M312645200 |
0.786 |
|
| 2003 |
Rao DS, Bradley SV, Kumar PD, Hyun TS, Saint-Dic D, Oravecz-Wilson K, Kleer CG, Ross TS. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells. Cancer Cell. 3: 471-82. PMID 12781365 DOI: 10.1016/S1535-6108(03)00107-7 |
0.793 |
|
| 2002 |
Rao DS, Hyun TS, Kumar PD, Mizukami IF, Rubin MA, Lucas PC, Sanda MG, Ross TS. Huntingtin-interacting protein 1 is overexpressed in prostate and colon cancer and is critical for cellular survival. The Journal of Clinical Investigation. 110: 351-60. PMID 12163454 DOI: 10.1172/Jci200215529 |
0.751 |
|
| 2001 |
Rao DS, Chang JC, Kumar PD, Mizukami I, Smithson GM, Bradley SV, Parlow AF, Ross TS. Huntingtin interacting protein 1 is a clathrin coat binding protein required for differentiation of late spermatogenic progenitors Molecular and Cellular Biology. 21: 7796-7806. PMID 11604514 DOI: 10.1128/Mcb.21.22.7796-7806.2001 |
0.766 |
|
| 2001 |
Mishra SK, Agostinelli NR, Brett TJ, Mizukami I, Ross TS, Traub LM. Clathrin- and AP-2-binding sites in HIP1 uncover a general assembly role for endocytic accessory proteins. The Journal of Biological Chemistry. 276: 46230-6. PMID 11577110 DOI: 10.1074/Jbc.M108177200 |
0.393 |
|
| 2001 |
Saint-Dic D, Chang SC, Taylor GS, Provot MM, Ross TS. Regulation of the Src homology 2-containing inositol 5-phosphatase SHIP1 in HIP1/PDGFbeta R-transformed cells. The Journal of Biological Chemistry. 276: 21192-8. PMID 11287412 DOI: 10.1074/Jbc.M008336200 |
0.5 |
|
| 1999 |
Ross TS, Gilliland DG. Transforming properties of the huntingtin interacting protein 1/platelet-derived growth factor β receptor fusion protein Journal of Biological Chemistry. 274: 22328-22336. PMID 10428802 DOI: 10.1074/Jbc.274.32.22328 |
0.469 |
|
| 1998 |
Schwaller J, Frantsve J, Aster J, Williams IR, Tomasson MH, Ross TS, Peeters P, Van Rompaey L, Van Etten RA, Ilaia R, Marynen P, Gilliland DG. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes Embo Journal. 17: 5321-5333. PMID 9736611 DOI: 10.1093/Emboj/17.18.5321 |
0.389 |
|
| 1998 |
Ross TS, Bernard OA, Berger R, Gilliland DG. Fusion of Huntingtin Interacting Protein 1 to Platelet-Derived Growth Factor β Receptor (PDGFβR) in Chronic Myelomonocytic Leukemia With t(5;7)(q33;q11.2) Blood. 91: 4419-4426. DOI: 10.1182/Blood.V91.12.4419.412K43_4419_4426 |
0.44 |
|
| 1998 |
Ross TS, Bernard OA, Berger R, Gilliland DG. Fusion of Huntingtin Interacting Protein 1 to Platelet-Derived Growth Factor β Receptor (PDGFβR) in Chronic Myelomonocytic Leukemia With t(5;7)(q33;q11.2) Blood. 91: 4419-4426. DOI: 10.1182/blood.v91.12.4419 |
0.332 |
|
| 1990 |
Majerus PW, Ross TS, Cunningham TW, Caldwell KK, Jefferson AB, Bansal VS. Recent insights in phosphatidylinositol signaling. Cell. 63: 459-65. PMID 2225061 DOI: 10.1016/0092-8674(90)90442-H |
0.3 |
|
| Show low-probability matches. |